- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 0.61 | -12.39 | 15.83 | 2.52 | 9.59 | 1.79 | N/A | - | ||
| 2026/3 | 0.7 | 45.81 | 0.06 | 1.91 | 7.72 | 1.91 | 0.48 | - | ||
| 2026/2 | 0.48 | -34.26 | 20.9 | 1.21 | 12.72 | 2.14 | 0.43 | - | ||
| 2026/1 | 0.73 | -21.44 | 7.91 | 0.73 | 7.91 | 2.34 | 0.39 | - | ||
| 2025/12 | 0.93 | 35.78 | 33.08 | 8.12 | 19.23 | 2.25 | 0.44 | - | ||
| 2025/11 | 0.68 | 7.84 | -7.4 | 7.19 | 17.65 | 1.97 | 0.5 | - | ||
| 2025/10 | 0.63 | -2.59 | 2.34 | 6.5 | 21.09 | 1.99 | 0.5 | - | ||
| 2025/9 | 0.65 | -7.31 | 3.27 | 5.87 | 23.54 | 2.01 | 0.4 | - | ||
| 2025/8 | 0.7 | 7.29 | 27.88 | 5.22 | 26.64 | 2.15 | 0.38 | - | ||
| 2025/7 | 0.65 | -17.01 | 17.02 | 4.51 | 26.45 | 2.21 | 0.37 | - | ||
| 2025/6 | 0.79 | 2.44 | 38.45 | 3.86 | 28.2 | 2.09 | 0.35 | - | ||
| 2025/5 | 0.77 | 45.61 | 18.54 | 3.07 | 25.81 | 2.0 | 0.37 | - | ||
| 2025/4 | 0.53 | -24.32 | 1.61 | 2.3 | 28.45 | 1.62 | 0.45 | - | ||
| 2025/3 | 0.7 | 76.19 | 81.58 | 1.77 | 39.44 | 1.77 | 0.42 | 膠原蛋白及玻尿酸產品，出貨較去年成長 | ||
| 2025/2 | 0.4 | -41.32 | 6.11 | 1.07 | 21.13 | 1.77 | 0.42 | - | ||
| 2025/1 | 0.68 | -3.12 | 32.09 | 0.68 | 32.09 | 2.11 | 0.35 | - | ||
| 2024/12 | 0.7 | -5.52 | 47.44 | 6.81 | 9.4 | 2.06 | 0.37 | - | ||
| 2024/11 | 0.74 | 19.2 | 32.75 | 6.11 | 6.27 | 1.99 | 0.38 | - | ||
| 2024/10 | 0.62 | -1.7 | 35.41 | 5.37 | 3.43 | 1.8 | 0.42 | - | ||
| 2024/9 | 0.63 | 14.76 | 41.93 | 4.75 | 0.34 | 1.74 | 0.43 | - | ||
| 2024/8 | 0.55 | -1.81 | -9.81 | 4.12 | -3.95 | 1.68 | 0.45 | - | ||
| 2024/7 | 0.56 | -1.81 | 3.45 | 3.57 | -2.98 | 1.78 | 0.42 | - | ||
| 2024/6 | 0.57 | -12.28 | -8.66 | 3.01 | -4.09 | 1.74 | 0.4 | - | ||
| 2024/5 | 0.65 | 24.81 | 15.7 | 2.44 | -2.96 | 1.56 | 0.45 | - | ||
| 2024/4 | 0.52 | 35.23 | -0.6 | 1.79 | -8.33 | 1.28 | 0.55 | - | ||
| 2024/3 | 0.38 | 2.96 | -33.19 | 1.27 | -11.16 | 1.27 | N/A | - | ||
| 2024/2 | 0.37 | -26.95 | -11.32 | 0.89 | 3.69 | 1.36 | N/A | - | ||
| 2024/1 | 0.51 | 8.13 | 18.34 | 0.51 | 18.34 | 1.54 | N/A | - | ||
| 2023/12 | 0.47 | -14.93 | -23.32 | 6.22 | 2.92 | 1.49 | N/A | - | ||
| 2023/11 | 0.56 | 21.58 | 6.42 | 5.75 | 5.91 | 1.46 | N/A | - | ||
| 2023/10 | 0.46 | 3.02 | -8.99 | 5.19 | 5.85 | 1.51 | N/A | - | ||
| 2023/9 | 0.44 | -27.08 | -25.05 | 4.73 | 7.55 | 1.59 | N/A | - | ||
| 2023/8 | 0.61 | 12.63 | 8.12 | 4.29 | 12.62 | 1.77 | N/A | - | ||
| 2023/7 | 0.54 | -13.31 | 15.09 | 3.68 | 13.41 | 1.73 | N/A | - | ||
| 2023/6 | 0.62 | 11.11 | 0.03 | 3.14 | 13.12 | 1.71 | N/A | - | ||
| 2023/5 | 0.56 | 7.22 | 7.13 | 2.52 | 16.92 | 1.66 | N/A | - | ||
| 2023/4 | 0.52 | -9.1 | 32.68 | 1.95 | 20.07 | 1.52 | N/A | - | ||
| 2023/3 | 0.58 | 36.67 | 24.25 | 1.43 | 16.03 | 1.43 | N/A | - | ||
| 2023/2 | 0.42 | -2.52 | 3.44 | 0.85 | 11.07 | 1.47 | N/A | - | ||
| 2023/1 | 0.43 | -29.94 | 19.68 | 0.43 | 19.68 | 1.57 | N/A | - | ||
| 2022/12 | 0.62 | 18.06 | 50.3 | 6.04 | 18.05 | 1.64 | N/A | 本月營收較去年同期增加，主要係因出貨量增加所致。 | ||
| 2022/11 | 0.52 | 3.97 | 20.46 | 5.43 | 15.24 | 1.62 | N/A | - | ||
| 2022/10 | 0.5 | -15.15 | -11.54 | 4.9 | 14.71 | 1.66 | N/A | - | ||
| 2022/9 | 0.59 | 5.2 | 7.0 | 4.4 | 18.74 | 1.63 | N/A | - | ||
| 2022/8 | 0.56 | 19.89 | 17.46 | 3.81 | 20.8 | 1.66 | N/A | - | ||
| 2022/7 | 0.47 | -24.65 | 33.47 | 3.25 | 21.4 | 1.62 | N/A | - | ||
| 2022/6 | 0.62 | 19.0 | 29.82 | 2.78 | 19.57 | 1.54 | N/A | - | ||
| 2022/5 | 0.52 | 32.78 | 21.56 | 2.15 | 16.9 | 1.38 | N/A | - | ||
| 2022/4 | 0.39 | -14.87 | 31.92 | 1.63 | 15.47 | 1.27 | N/A | - | ||
| 2022/3 | 0.46 | 13.78 | -4.66 | 1.23 | 11.03 | 1.23 | N/A | - | ||
| 2022/2 | 0.41 | 12.77 | 7.4 | 0.77 | 23.28 | 1.18 | N/A | - | ||
| 2022/1 | 0.36 | -12.01 | 47.96 | 0.36 | 47.96 | 1.21 | N/A | - | ||
| 2021/12 | 0.41 | -5.37 | -35.68 | 5.12 | 11.86 | 1.41 | N/A | - | ||
| 2021/11 | 0.43 | -23.64 | 9.6 | 4.71 | 19.56 | 1.56 | N/A | - | ||
| 2021/10 | 0.57 | 2.63 | 192.08 | 4.27 | 20.68 | 1.6 | N/A | 本月營收較去年同期增加，主要係因出貨量增加所致。 | ||
| 2021/9 | 0.55 | 15.48 | 8.0 | 3.71 | 10.71 | 1.39 | N/A | - | ||
| 2021/8 | 0.48 | 36.23 | 27.48 | 3.15 | 11.2 | 1.31 | N/A | - | ||
| 2021/7 | 0.35 | -26.71 | 34.59 | 2.67 | 8.71 | 1.26 | N/A | - | ||
| 2021/6 | 0.48 | 11.43 | -2.36 | 2.32 | 5.63 | 0.0 | N/A | - | ||
| 2021/5 | 0.43 | 44.09 | 14.23 | 1.84 | 7.94 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 0.73 | 2025/1 | 0.68 | 2024/1 | 0.51 | 2023/1 | 0.43 | 2022/1 | 0.36 |
| 2026/2 | 0.48 | 2025/2 | 0.4 | 2024/2 | 0.37 | 2023/2 | 0.42 | 2022/2 | 0.41 |
| 2026/3 | 0.7 | 2025/3 | 0.7 | 2024/3 | 0.38 | 2023/3 | 0.58 | 2022/3 | 0.46 |
| 2026/4 | 0.61 | 2025/4 | 0.53 | 2024/4 | 0.52 | 2023/4 | 0.52 | 2022/4 | 0.39 |
| N/A | N/A | 2025/5 | 0.77 | 2024/5 | 0.65 | 2023/5 | 0.56 | 2022/5 | 0.52 |
| N/A | N/A | 2025/6 | 0.79 | 2024/6 | 0.57 | 2023/6 | 0.62 | 2022/6 | 0.62 |
| N/A | N/A | 2025/7 | 0.65 | 2024/7 | 0.56 | 2023/7 | 0.54 | 2022/7 | 0.47 |
| N/A | N/A | 2025/8 | 0.7 | 2024/8 | 0.55 | 2023/8 | 0.61 | 2022/8 | 0.56 |
| N/A | N/A | 2025/9 | 0.65 | 2024/9 | 0.63 | 2023/9 | 0.44 | 2022/9 | 0.59 |
| N/A | N/A | 2025/10 | 0.63 | 2024/10 | 0.62 | 2023/10 | 0.46 | 2022/10 | 0.5 |
| N/A | N/A | 2025/11 | 0.68 | 2024/11 | 0.74 | 2023/11 | 0.56 | 2022/11 | 0.52 |
| N/A | N/A | 2025/12 | 0.93 | 2024/12 | 0.7 | 2023/12 | 0.47 | 2022/12 | 0.62 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.33 | 120.0 | 120.0 |
| 25Q4 (7) | 0.15 | -21.05 | -34.78 |
| 25Q3 (6) | 0.19 | 46.15 | -52.5 |
| 25Q2 (5) | 0.13 | -13.33 | 18.18 |
| 25Q1 (4) | 0.15 | -34.78 | 0.0 |
| 24Q4 (3) | 0.23 | -42.5 | 0.0 |
| 24Q3 (2) | 0.4 | 263.64 | 0.0 |
| 24Q2 (1) | 0.11 | 0.0 | 0.0 |